-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Dyne Therapeutics, Lowers Price Target to $17

Benzinga·03/21/2025 16:18:19
Listen to the news
JP Morgan analyst Tessa Romero maintains Dyne Therapeutics (NASDAQ:DYN) with a Neutral and lowers the price target from $18 to $17.